No Stock Yet
Langzi Co., Ltd. (002612.SZ): Shen Dongri plans to transfer 5% of the shares to his spouse Weng Jie
Glonghui, Feb. 7 丨 Langzi Co., Ltd. (002612.SZ) announced that on February 7, 2023, Shen Dongri, one of the company's controlling shareholders and actual controllers, signed a “Share Transfer Agreement” with her spouse Weng Jie due to family asset planning needs, and transferred 221222.69 million unrestricted tradable shares of the company (accounting for 5% of the company's total share capital) to Weng Jie. This share transfer is due to a change in the company's controlling shareholder and the members acting in concert. Their total shareholding ratio, quantity, and voting rights have not changed, and there is no reduction in holdings to the market.
Medical and aesthetic concept stocks fluctuated lower, with the Golden Laby falling more than 7%, while Aoyuan Meigu, International Medicine, Langzi Co., Ltd. and Lu Shang Development followed suit.
Langzi Co., Ltd. (002612): Short-term performance is pressured and optimistic about post-epidemic recovery performance
Core view: The company released its 2022 performance forecast, and performance is under pressure. The company is expected to achieve net profit of 0.20-0.3 billion yuan in 2022, a year-on-year decrease of 84.00%-89.33%, after deducting net profit of 0.09-14 million yuan, a year-on-year decrease of 92.67-95.11%. Quarterly, Q4 expects net profit attributable to the mother to fall 57.34-91.54% year on year, and net profit after deducting the return of the mother to the mother falls 121.63%-136.29% year on year. The main reasons for the pressure on the company's performance in 2022 are: (1) Affected by the epidemic
Wakawa Chen (003010.SZ) shareholder Langzi Co., Ltd. reduced its holdings by a total of 2.176,900 shares
According to the Zhitong Finance App, Ruo Yu Chen (003010.SZ) issued an announcement. Recently, the company received a “Notice on the Progress of Implementation of the Share Holding Reduction Plan” issued by Langzi Co., Ltd. As of the disclosure date of this announcement, the holdings reduction plan had already passed halfway through the planned period, with a total reduction of 2.1769 million shares, accounting for 1.7887% of the company's total share capital.
Langzi Co., Ltd. (002612.SZ) issued a forecast reduction. Net profit of 20 million yuan to 30 million yuan in 2022 is expected to decrease 84%-89.33% year-on-year
According to the Zhitong Finance App, Langzi Co., Ltd. (002612.SZ) released its 2022 annual performance forecast. The net profit attributable to shareholders of listed companies for the whole year is 20 million yuan to 30 million yuan, a year-on-year decrease of 84%-89.33%. The main reasons for the year-on-year decline in performance were: 1. Affected by the COVID-19 pandemic and the epidemic prevention policy, some of the company's offline stores and business institutions were temporarily closed and passenger traffic declined in the short term; 2. Many new women's clothing stores and new medical and aesthetic institutions were opened in 2021, which led to a large year-on-year increase in sales expenses and management expenses in the current period; 3. New institutions in the medical and aesthetic sector,
Sector changes | Sichuan birth registration lifted restrictions on number of births, three-child concept stocks surged in the afternoon
The Zhitong Finance App learned that on January 30, due to news that birth registration in Sichuan lifted restrictions on the number of births, A-share three-child concept stocks soared in the afternoon. As of press release, Megim (002621.SZ) rose and stopped, and shares such as Kid Wang (301078.SZ), Shengtong Co., Ltd. (002599.SZ), Langzi (002612.SZ), Fuori (002083.SZ), Baby-Friendly Room (603214.SH), Onli Education (600661.SH), Tiancheng Auto Control (), and Tiancheng Auto Control () rose. 603085.SH The Sichuan Health Commission recently released “Sichuan Students
Langzi Co., Ltd. (002612) Company Information Update Report: Net profit returned to the mother in 2022 is expected to decline 84%-89% year-on-year, optimistic about the recovery of the company's medical and aesthetic business in 2023
Incident: The company released a performance forecast. It is expected that the net profit of returning to the mother in 2022 will fall 84%-89% year on year. The company released the 2022 performance forecast: it is expected to achieve net profit of 20 million yuan to 30 million yuan in 2022 (down 84.00%-89.33% year on year). In 2022 Q4 alone, it is expected to achieve a net profit of 2.48 million yuan to 12.48 million yuan (down 57.34%-91.54% year on year) due to the impact of the epidemic. Considering the impact of the 202Q4 epidemic, we lowered our profit forecast for 2022, which is expected to be public
Changes in the beauty care sector boosted Bethenny's rise by more than 5%
The abnormal movement of the medical beauty concept plate has led to a rise of more than 7% in Aoyuan Meigu.
Medical and aesthetic concept stocks strengthened, Aoyuan Miya rose and stopped
Glonghui, January 5, 丨 Aoyuan Beauty Valley rose and stopped, Jimin Medical, Langzi, and Imeke rose more than 5%, while Huadong Pharmaceutical, Haohai Biotech, Beitani, Huaxi Biotech, and Harbin Sanlian followed suit.
No Stock Yet